Ceramides surpass LDL-cholesterol in predicting cardiovascular mortality in patients with as well as in patients without the metabolic syndrome

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Cardiovascular risk assessment: biomarkers (2) Biomarkers ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

ESC 365 is supported by

ESC 365 is supported by